세계의 세포 동결보존 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Cell Cryopreservation Market size is anticipated to grow from USD 23.79 Billion in 2024 to USD 150.51 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 22.75% during the forecast period of 2026 to 2033.

The Cell Cryopreservation market is poised for significant growth, driven by the increasing demand for cell-based therapies, regenerative medicine, and advancements in biobanking technologies. Cryopreservation, the process of cooling and storing cells at very low temperatures to halt biological activity, is essential for preserving the viability and functionality of various cell types, including stem cells, immune cells, and reproductive cells. As the global focus on personalized medicine and innovative therapeutic approaches intensifies, the need for effective cryopreservation techniques is becoming increasingly critical. This market encompasses a wide range of products and services, including cryopreservation equipment, cryoprotectants, and storage solutions, all designed to ensure the integrity of biological samples over extended periods.

Technological advancements are significantly shaping the Cell Cryopreservation market, with innovations in cryopreservation methods and equipment enhancing the efficiency and reliability of the process. The development of automated cryopreservation systems and advanced monitoring technologies is improving the precision of temperature control and reducing the risk of ice crystal formation, which can compromise cell viability. Additionally, the integration of artificial intelligence and data analytics in cryopreservation protocols is enabling researchers and clinicians to optimize storage conditions and predict cell behavior post-thaw. As the market continues to evolve, companies that prioritize research and development to enhance their cryopreservation solutions will likely capture a larger share of the growing demand.

Moreover, the Cell Cryopreservation market is increasingly influenced by regulatory frameworks and ethical considerations surrounding the use of human cells and tissues. As biobanks and research institutions strive to comply with stringent regulations, the demand for standardized and validated cryopreservation protocols will continue to rise. This trend is driving investment in training and certification programs for personnel involved in cell handling and storage, ensuring that best practices are followed. Furthermore, the growing emphasis on sustainability and environmental responsibility in the life sciences sector is prompting companies to explore eco-friendly cryopreservation solutions. As the focus on cell-based therapies and regenerative medicine expands, the need for reliable and efficient cryopreservation methods will be paramount, positioning companies that align their offerings with industry needs for success in this dynamic market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

• Cryopreservation Media Agent (Ethylene Glycol, Dimethyl Sulfoxide, Glycerol, Others)
• Equipment Type (Freezers, Liquid Nitrogen Supply Tanks, Others)

By Application

• Stem Cells
• Oocytes Cells
• Sperm Cells
• Others

By End User

• Pharmaceutical And Biotechnology Company
• Research Institute
• Others
• COMPANIES PROFILED
• PromoCell GmbH
• BioLife Solutions Inc.
• HiMedia Laboratories
• Merck Group KGaA
• Lonza
• Thermo Fisher Scientific Inc.
• Eppendorf Corporate
• Sartorius AG
• Creative Biolabs
• Danaher Corporation
• The above list can be customized.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL CRYOPRESERVATION INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Cell Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents) Historic and Forecast Sales by Regions
• 5.5 Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables) Historic and Forecast Sales by Regions

6 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY CELL TYPE

• 6.1 Overview by Cell Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Cell Type
• 6.4 Stem Cells Historic and Forecast Sales by Regions
• 6.5 Oocytes And Embryotic Cells Historic and Forecast Sales by Regions
• 6.6 Sperm Cells Historic and Forecast Sales by Regions
• 6.7 Hepatocytes Historic and Forecast Sales by Regions
• 6.8 Other Historic and Forecast Sales by Regions

7 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Drug Discovery And Development Historic and Forecast Sales by Regions
• 7.5 Regenerative Medicine Historic and Forecast Sales by Regions
• 7.6 Organ Transplantation Historic and Forecast Sales by Regions
• 7.7 Clinical Research Historic and Forecast Sales by Regions
• 7.8 Other Historic and Forecast Sales by Regions

8 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY END-USE

• 8.1 Overview by End-use
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-use
• 8.4 Hospitals And Clinics Historic and Forecast Sales by Regions
• 8.5 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
• 8.6 Research And Academic Institutes Historic and Forecast Sales by Regions
• 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions

9 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CELL CRYOPRESERVATION COMPANIES

• 10.1. Cell Cryopreservation Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF CELL CRYOPRESERVATION INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Thermo Fisher Scientific Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Sartorius AG
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. PromoCell GmbH
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. BioLife Solutions Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Merck KGaA
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. HiMedia Laboratories
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Creative Biolabs
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Corning Incorporated
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. GE Healthcare
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Danaher Corporation
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies